MedTrace Logo

Persistent Pulmonary Hypertension After Percutaneous Mitral Commissurotomy

NCT04083729 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 62

Last updated 2019-09-10

No results posted yet for this study

Summary

To identify clinical, echocardiographic, and hemodynamic parameters which can predict persistent PH after PMC, and also to determine the impact of persistent PH on the clinical outcomes.

Conditions

  • Pulmonary Hypertension

Interventions

PROCEDURE

Percutaneous Mitral Commissurotomy

Percutaneous mitral commissurotomy is performed by experienced interventional cardiologists using the Inoue balloon or multitrack technique. During the procedure, conventional hemodynamic parameters are monitored. A successful immediate result is defined as a mitral valve area \> 1.5 square cm with less than moderate to severe mitral regurgitation.

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • mohamed Abdelghany Koreim · Assiut University, 71515 Assiut, Egypt.

  • Hosam Hasan El Araby · Assiut University, 71515 Assiut, Egypt.

  • Amr ElBadry Ibrahim · Assiut University, 71515 Assiut, Egypt.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-09-30
Primary Completion
2021-09-30
Completion
2021-10-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04083729 on ClinicalTrials.gov